After one year, mortality rates between the low- and high-risk groups differed more than 20 percent, with low-risk mortality at 5.2 percent and high-risk mortality at 26.7 percent. Despite their much higher death risk, the patients with the worst health derived the most health benefits from receiving a transplant.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Factors that put patients at a higher risk of post-transplant mortality included older age, congenital heart disease, cardiomyopathy, ventilator support, mechanical support and/or kidney dysfunction.
Researchers concluded this new risk estimate suggests current transplant waiting list systems may not provide maximal benefits from the available transplant organs, which a reorganization of the waiting list based on risk might accomplish.
More Articles on Quality:
Patient Navigators Facilitate Successful Chronic Care, Study Finds
Tips on Improving OR Management From Surgical Directions
Reducing Readmissions to Reduce Penalties: Where to Begin?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
